O-GlcNAcylation in health and neurodegenerative diseases

Exp Mol Med. 2021 Nov;53(11):1674-1682. doi: 10.1038/s12276-021-00709-5. Epub 2021 Nov 26.

Abstract

O-GlcNAcylation is a posttranslational modification that adds O-linked β-N-acetylglucosamine (O-GlcNAc) to serine or threonine residues of many proteins. This protein modification interacts with key cellular pathways involved in transcription, translation, and proteostasis. Although ubiquitous throughout the body, O-GlcNAc is particularly abundant in the brain, and various proteins commonly found at synapses are O-GlcNAcylated. Recent studies have demonstrated that the modulation of O-GlcNAc in the brain alters synaptic and neuronal functions. Furthermore, altered brain O-GlcNAcylation is associated with either the etiology or pathology of numerous neurodegenerative diseases, while the manipulation of O-GlcNAc exerts neuroprotective effects against these diseases. Although the detailed molecular mechanisms underlying the functional roles of O-GlcNAcylation in the brain remain unclear, O-GlcNAcylation is critical for regulating diverse neural functions, and its levels change during normal and pathological aging. In this review, we will highlight the functional importance of O-GlcNAcylation in the brain and neurodegenerative diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylglucosamine / metabolism*
  • Aging / metabolism
  • Animals
  • Biomarkers
  • Brain / metabolism
  • Diagnosis, Differential
  • Disease Susceptibility
  • Gene Expression Regulation
  • Glycosylation
  • Homeostasis*
  • Humans
  • Neurodegenerative Diseases / diagnosis
  • Neurodegenerative Diseases / etiology*
  • Neurodegenerative Diseases / metabolism*
  • Neurons / metabolism
  • Protein Processing, Post-Translational*

Substances

  • Biomarkers
  • Acetylglucosamine